vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $31.4M, roughly 1.4× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -19.9%, a 56.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 37.6%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 23.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
ABCL vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $31.4M |
| Net Profit | $-8.9M | $10.1M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 43.6% |
| Net Margin | -19.9% | 36.3% |
| Revenue YoY | 788.4% | 37.6% |
| Net Profit YoY | 73.9% | 245.6% |
| EPS (diluted) | $-0.03 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $31.4M | ||
| Q3 25 | $9.0M | $26.7M | ||
| Q2 25 | $17.1M | $26.5M | ||
| Q1 25 | $4.2M | $24.6M | ||
| Q4 24 | $5.0M | $22.8M | ||
| Q3 24 | $6.5M | $20.2M | ||
| Q2 24 | $7.3M | $20.2M | ||
| Q1 24 | $10.0M | $20.5M |
| Q4 25 | $-8.9M | $10.1M | ||
| Q3 25 | $-57.1M | $6.5M | ||
| Q2 25 | $-34.7M | $6.1M | ||
| Q1 25 | $-45.6M | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | $-51.1M | $2.4M | ||
| Q2 24 | $-36.9M | $3.2M | ||
| Q1 24 | $-40.6M | $2.4M |
| Q4 25 | -63.7% | 43.6% | ||
| Q3 25 | -851.8% | 32.8% | ||
| Q2 25 | -290.2% | 30.2% | ||
| Q1 25 | -1479.6% | 32.5% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | -1439.4% | 15.2% | ||
| Q2 24 | -1276.2% | 21.8% | ||
| Q1 24 | -551.5% | 18.3% |
| Q4 25 | -19.9% | 36.3% | ||
| Q3 25 | -637.8% | 24.3% | ||
| Q2 25 | -203.3% | 23.0% | ||
| Q1 25 | -1077.2% | 24.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | -785.4% | 12.1% | ||
| Q2 24 | -504.3% | 15.8% | ||
| Q1 24 | -408.0% | 11.8% |
| Q4 25 | $-0.03 | $0.43 | ||
| Q3 25 | $-0.19 | $0.27 | ||
| Q2 25 | $-0.12 | $0.25 | ||
| Q1 25 | $-0.15 | $0.25 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | $-0.17 | $0.10 | ||
| Q2 24 | $-0.13 | $0.14 | ||
| Q1 24 | $-0.14 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $966.9M | $541.5M |
| Total Assets | $1.4B | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $126.2M | ||
| Q3 25 | $83.2M | $146.6M | ||
| Q2 25 | $92.4M | $126.6M | ||
| Q1 25 | $159.3M | $129.9M | ||
| Q4 24 | $156.3M | $139.8M | ||
| Q3 24 | $126.6M | $155.8M | ||
| Q2 24 | $148.3M | $103.2M | ||
| Q1 24 | $123.6M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $966.9M | $541.5M | ||
| Q3 25 | $964.0M | $529.8M | ||
| Q2 25 | $1.0B | $521.1M | ||
| Q1 25 | $1.0B | $513.9M | ||
| Q4 24 | $1.1B | $505.5M | ||
| Q3 24 | $1.1B | $504.6M | ||
| Q2 24 | $1.1B | $497.7M | ||
| Q1 24 | $1.1B | $493.7M |
| Q4 25 | $1.4B | $3.2B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.4B | $3.2B | ||
| Q1 25 | $1.3B | $3.1B | ||
| Q4 24 | $1.4B | $3.0B | ||
| Q3 24 | $1.4B | $3.0B | ||
| Q2 24 | $1.4B | $2.8B | ||
| Q1 24 | $1.5B | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $55.6M |
| Free Cash FlowOCF − Capex | $-44.6M | $54.6M |
| FCF MarginFCF / Revenue | -99.4% | 173.9% |
| Capex IntensityCapex / Revenue | 21.9% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $55.6M | ||
| Q3 25 | $-52.6M | $1.4M | ||
| Q2 25 | $-32.4M | $6.2M | ||
| Q1 25 | $-11.6M | $13.1M | ||
| Q4 24 | $-108.6M | $7.2M | ||
| Q3 24 | $-28.9M | $-14.6M | ||
| Q2 24 | $-30.0M | $-2.6M | ||
| Q1 24 | $-41.7M | $1.5M |
| Q4 25 | $-44.6M | $54.6M | ||
| Q3 25 | $-61.5M | $786.0K | ||
| Q2 25 | $-45.8M | $5.9M | ||
| Q1 25 | $-22.2M | $12.9M | ||
| Q4 24 | $-187.0M | $4.5M | ||
| Q3 24 | $-47.4M | $-15.0M | ||
| Q2 24 | $-50.1M | $-2.6M | ||
| Q1 24 | $-65.8M | $-315.0K |
| Q4 25 | -99.4% | 173.9% | ||
| Q3 25 | -687.0% | 2.9% | ||
| Q2 25 | -267.9% | 22.4% | ||
| Q1 25 | -524.0% | 52.6% | ||
| Q4 24 | -3702.8% | 19.7% | ||
| Q3 24 | -728.4% | -74.1% | ||
| Q2 24 | -683.8% | -13.0% | ||
| Q1 24 | -661.5% | -1.5% |
| Q4 25 | 21.9% | 3.1% | ||
| Q3 25 | 99.7% | 2.3% | ||
| Q2 25 | 78.2% | 1.0% | ||
| Q1 25 | 251.1% | 0.6% | ||
| Q4 24 | 1552.7% | 11.9% | ||
| Q3 24 | 284.6% | 2.0% | ||
| Q2 24 | 274.6% | 0.3% | ||
| Q1 24 | 242.5% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
